About this trial
The CLEAR-PC project addresses the critical issue of low health literacy in prostate cancer prevention and care, recognising that inadequate health literacy leads to difficulties in understanding complex medical information, limits shared decision making, and increases health inequalities. Given the high prevalence and complexity of prostate cancer, the project aims to design and development of a comprehensive strategy to improve health literacy in the Prostate cancer prevention and care, considering individual capacities, the role of healthcare professionals and organisations, and the influence of social and cultural contexts. In the design and development of this new strategy, the investigators apply both action research and cocreation methodologies because by involving all stakeholders (general population, vulnerable population patients, health professionals, policy makers and other target groups), we ensure that the resulting strategy is user-centred, implementable and responsive to their needs. The design and development of the new strategy will follow a systematic cycle: (a) problem diagnosis by assessing individual contexts, healthcare professionals, organisational aspects and the social framework; (b) adaptation of existing health literacy tools to the specific context of prostate cancer prevention and care, integrating them into a new strategy, followed by evaluation of their usability and acceptability; and (c) observation of results in practice and reflection. Co-creation will be a critical component throughout this process, ensuring that stakeholders are actively involved at every stage, from diagnosis of challenges to refinement and validation of solutions. The consortium, composed of institutions from Spain, Portugal, Croatia, Belgium, the Netherlands and Cyprus, leverages multidisciplinary expertise to create digital and non-innovative tools and educational resources to address public health disparities, reduce misinformation and support decision-making on prostate cancer prevention and care.
Eligibility criteria
Qualifiers
Adults aged 40 years or older
Member of the general population, patient, caregiver, or healthcare professional eligible for the study component
Able to understand and communicate in the language used at the study site
Able to provide informed consent
Disqualifiers
Participation in another study that could interfere with the outcomes of this study
Trial design
Treatments tested in this trial
- Co-created digital health literacy intervention for prostate cancer prevention and care
Treatment groups
Sponsors and collaborators
Universidad Miguel Hernandez de Elche
Lead sponsor
Canary Islands Health Service
Collaborator
Ordem dos Psicólogos
Collaborator
Public Open University Čakovec
Collaborator
Thomas More University of Applied Sciences
Collaborator
Erasmus Medical Center
Collaborator
Center for Social Innovation
Collaborator
Instituto de Investigación Sanitaria y Biomédica de Alicante
Collaborator
Europa UOMO
Collaborator
Spanish Society of Family and Community Medicine
Collaborator
FISABIO (Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community)
Collaborator
Universidad de Murcia
Collaborator
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Collaborator
FEFOC fundation
Collaborator
Ministry of Health - Government of the Principality of Asturias
Collaborator
Asturias Public Health Service (SESPA)
Collaborator
Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y Tecnologia
Collaborator